Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries (NY: BLCO ) 20.63 -0.30 (-1.43%) Official Closing Price Updated: 7:00 PM EDT, Oct 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about BLCO < Previous 1 2 3 4 5 6 Next > Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Ophthalmology Annual Meeting October 26, 2023 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Will Release Third-Quarter 2023 Financial Results on November 1 October 16, 2023 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Will Present New Scientific Data and Analyses at American Academy of Optometry Annual Meeting October 04, 2023 From Bausch + Lomb Via Business Wire 6 Analysts Have This to Say About Bausch & Lomb October 03, 2023 Via Benzinga Earnings Preview: Bausch & Lomb August 01, 2023 Via Benzinga Analyst Ratings for Bausch & Lomb July 24, 2023 Via Benzinga Novartis Mulls Divesting Some Assets Of Radiopharma Unit In Strategic Shift October 03, 2023 Swiss pharmaceutical giant Novartis AG (NYSE: NVS) is reportedly contemplating selling sections of radiopharmaceuticals company Advanced Accelerator Applications to align with the company's strategy... Via Benzinga Bausch Health's Bausch + Lomb Announces Completion of the Acquisition of XIIDRA(R) September 29, 2023 Via ACCESSWIRE Bausch + Lomb Completes Acquisition of XIIDRA® September 29, 2023 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Launches LUMIFY EYE ILLUMINATIONS™ in the United States September 26, 2023 From Bausch + Lomb Corporation Via Business Wire Analyst Ratings for Bausch & Lomb July 03, 2023 Via Benzinga Bausch + Lomb’s ONE by ONE and Biotrue® Eye Care Recycling Programs Recognized As Sustainability Service of the Year Award Winners September 20, 2023 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Announces Pricing of Senior Secured Notes Offering September 14, 2023 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Launches MIEBO™ (Perfluorohexyloctane Ophthalmic Solution) in the United States September 12, 2023 From Bausch + Lomb Corporation Via Business Wire Bausch Health's Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA(R) September 11, 2023 Via ACCESSWIRE Bausch + Lomb Announces Launch of Proposed Financing for Acquisition of XIIDRA® September 11, 2023 From Bausch + Lomb Corporation Via Business Wire Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030 September 08, 2023 EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(OTCQX:RHHBY) EQNX::TICKER_END Via FinancialNewsMedia Exposures COVID-19 Bausch + Lomb Announces Disclosure of Historical and Pro Forma Financial Information With Respect to Acquisition of XIIDRA® September 06, 2023 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Will Present New Scientific Data on its Surgical Products and Pipeline at European Society of Cataract and Refractive Surgery Annual Meeting September 06, 2023 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Will Participate at the 2023 Wells Fargo Healthcare Conference August 29, 2023 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Announces Expiration of Hart-Scott-Rodino Waiting Period for Acquisition of XIIDRA® August 24, 2023 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Announces Second-Quarter 2023 Results and Raises Full-Year 2023 Revenue Outlook August 02, 2023 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Solidifies Leadership Team August 01, 2023 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Will Release Second-Quarter 2023 Financial Results on August 2 July 11, 2023 From Bausch + Lomb Corporation Via Business Wire Bausch + Lomb Expands OTC Eye Care Portfolio, Acquires JNJ's Blink July 06, 2023 Bausch + Lomb Corporation (NYSE: BLCO) has acquired Johnson & Johnson's (NYSE: JNJ) eye and contact lens drops brand Blink for $106.5 million to bolster its position in over-the-counter (OTC)... Via Benzinga Bausch + Lomb Expands OTC Product Line with Acquisition of Blink® Eye Drops July 06, 2023 From Bausch + Lomb Corporation Via Business Wire Carnival, SMART Global, Friedman Industries And Other Big Stocks Moving Higher On Friday June 30, 2023 U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording gains in today’s session. Via Benzinga Amazon Hires Dozens of Former FTC Officials, Volkswagen Discusses With Tesla to Adopt North American Charging Standard, FDA Approves First Hemophilia A BioMarin Gene Therapy: Today's Top Stories June 30, 2023 New York Post Via Benzinga Bausch + Lomb Poised To Boost Presence In Growing Market With Potential $1.75B Drug Acquisition Deal From Novartis June 30, 2023 Bausch + Lomb Corporation (NYSE: BLCO) has agreed to acquire 'front of eye' ophthalmology assets for $1.75 billion in upfront cash, plus additional milestone payments from Novartis AG (NYSE: Via Benzinga Bausch Health’s Bausch + Lomb to Acquire Novartis’ XIIDRA(R) June 30, 2023 Via ACCESSWIRE < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.